The global erythrocyte catalase market is anticipated to grow at a high CAGR during the forecast period. The major factor for the growth of the market is the increasing consumption of treated water with hydrogen peroxide without taking precautionary measures, and increasing contact with disinfectants, these all factors will fuel the demand for the market during the forecast period.
Erythrocyte catalase is used for the protection of haemoglobin by removing the hydrogen peroxide which is generated by erythrocytes. With increasing anaemia cases across the globe that causes iron deficiency, this factor will fuel the growth of the market during the forecast period. Due to the iron deficiency, iron-dependent enzymes like catalase are affected and they cannot function which can lead to RBCs getting lysed easily by the peroxide and their lifespan cut short. To prevent this catalase treatment is given which has proven effective. According to the WHO, around 42% of children aged less than 5 years and 40% of pregnant women worldwide are anaemic every year. These factors will fuel the demand during the forecast period. Some of the key global players in the global erythrocyte catalase market include Novozymes, Genecor, AB Enzymes, SunHY, Shandong Longda, and many others.
Market Coverage
o By Type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Erythrocyte Catalase Market by Segments
o CAT
o Decomposing Enzyme
o Food
o Medicine
o Others
Global Erythrocyte Catalase Market by Region
North America
Europe
Asia-Pacific
Rest of the World
REQUEST FOR TABLE
OF CONTENT